Simon (Chong) Chu

Principal Scientist at ROME Therapeutics

Simon (Chong) Chu has worked at Harvard Medical School since 2017, where they have held the role of Research Fellow. Simon (Chong) is currently transitioning to ROME Therapeutics, where they will serve as Principal Scientist beginning in 2022.

Simon (Chong) Chu received their Doctor of Philosophy - PhD in Computer Science from the University of Connecticut in 2017. Prior to that, they studied Computer Science at Beijing University of Chemical Technology.

Links


Org chart

Timeline

  • Principal Scientist

    July, 2022 - present